MAM
L&K Saatchi & Saatchi hires Reliance Jio’s Meraj Hasan as VP – planning
MUMBAI: L&K Saatchi & Saatchi has named Meraj Hasan as vice president – planning.
He joins the agency from Reliance Industries, where he was working on the company’s 4G service – Jio and will be based out of Mumbai.
L&K Saatchi & Saatchi CEO and managing partner Anil S Nair said, “Meraj’s appointment is part of a significant ramp up in our strategic planning division. Our sincere attempt is to make each and every brand at L&K Saatchi & Saatchi a Lovemark and hence give it the highest possible strategic input.Meraj comes as a leader who will drive this agenda across as many brands in the Mumbai office.”
Hasan added, “An opportunity to strategically steer some of the best global as well local brands in the country is what pulled me towards L&K Saatchi & Saatchi, when I wanted to do my ‘Gharwapsi’ of sorts to advertising. A few meetings with Anil and the gang and exposure to the rocking work that they are doing confirmed that this is perfect place to do so. We found our fit in each other.”
“Today’s consumer isn’t just buying a brand, she is buying into cohesive and compelling storyline around the brand, irrespective of the platforms and Lovemarks is a fantastic way of doing so. The idea is to build an enthusiastic team of bright minds and tell such stories for our brand. I’m really looking forward to this gig,” he added.
In his career spanning more than 15 years, Hasan has worked across agencies like Lowe Worldwide, Y&R, Ogilvy, TBWA and McCann.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
